Health ❯ Healthcare ❯ Mental Health

Substance Use Disorders

Alcohol Use Disorder Cannabis Use Disorder Addiction Risks GLP-1 Effects Opioid Misuse Ethics in Medicine Addiction Treatment Treatment Facilities Ketamine Treatment Data Standards

Clearmind’s AUD Candidate Meets Early Safety Goal as Shares Double

The non-hallucinogenic MEAI pill advanced past the dose-escalation safety gate.

GLP-1 Drugs Tied to Lower Addiction Risk and Harms in Large VA Study

Doctor in Matthew Perry Ketamine Case Gets Eight Months of Home Confinement

Wearable HRV Patch Cut Daily Substance Use 64% in Phase II Trial

California Addiction Treatment Center and Anthem to Face Fall Arbitration Over Denied Claims

Varenicline-Bupropion Combination Doubles Treatment Effectiveness for Alcohol Use Disorder

Ibudilast Fails in Alcohol Use Disorder Trial, Curbs Drinking Among Women

Frankfurt's Crack Support Center Plan Faces Political Rift Ahead of City Parliament Vote

Study Maps Broad Health Impacts of Popular GLP-1 Weight-Loss Drugs

Study Reveals High Rates of Opioid Misuse Among Chronic Pain Patients